TICTAC: target illumination clinical trial analytics with cheminformatics
IntroductionIdentifying disease–target associations is a pivotal step in drug discovery, offering insights that guide the development and optimization of therapeutic interventions. Clinical trial data serves as a valuable source for inferring these associations. However, issues such as inconsistent...
Saved in:
| Main Authors: | Jeremiah I. Abok, Jeremy S. Edwards, Jeremy J. Yang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Bioinformatics |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fbinf.2025.1579865/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Fifteen years of ChEMBL and its role in cheminformatics and drug discovery
by: Barbara Zdrazil
Published: (2025-03-01) -
Current Trends in Clinical Trials of Prodrugs
by: Diogo Boreski, et al.
Published: (2025-02-01) -
Combining genetic proxies of drug targets and time-to-event analyses from longitudinal observational data to identify target patient populations
by: Luke Zhang, et al.
Published: (2025-05-01) -
Exploring Quinazoline as a Scaffold for Developing Novel Therapeutics in Alzheimer’s Disease
by: Qais Abualassal, et al.
Published: (2025-01-01) -
Clinical significance of lipid pathway-targeted therapy in breast cancer
by: Dan Li, et al.
Published: (2025-01-01)